|Articles|September 1, 1996

The American Journal of Managed Care

  • September 1996
  • Volume 2
  • Issue 8

Pharmacoeconomic Evaluation of HMG-CoA Reductase Inhibitors in the Treatment of Hypercholestrolemia

Download PDF: Pharmacoeconomic Evaluation of HMG-CoA Reductase Inhibitors in the Treatment of Hypercholestrolemia

Articles in this issue

over 29 years ago

Determinants of Hospital Charges and Costs in Acute Myocardial Infarction: A Report from the Myocardial Infarction Cost Study (MICS) Group

over 29 years ago

The Effectiveness of Postgraduate Education on the Clinical Breast Examination Skills of Primary Care Physicians

over 29 years ago

Treatment Outcome in an Outpatient Asthma Center: Retrospective Questionnaire Data

over 29 years ago

Potential Cost-Effectiveness of Acute Stroke Treatment

over 29 years ago

Effect of a Comprehensive Nurse-Managed Diabetes Program: An HMO Prospective Study

over 29 years ago

The Economic Organization of Health Resource Allocation: Decision Making in the New Environment

over 29 years ago

Potential for SSRIs as Monotherapy for Comorbid Psychiatric Disorders

over 29 years ago

Establishing the Basis for Successful Disease Management Contracting

over 29 years ago

Accreditation Standards in Managed Care

over 29 years ago

A Closer Look at Capitation

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text